NKTR Insider Trading

Insider Ownership Percentage: 3.38%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,549,090.27

Nektar Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Nektar Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Nektar Therapeutics Share Price & Price History

Current Price: $2.90
Price Change: Price Decrease of -0.01 (-0.34%)
As of 12/8/2022 01:00 AM ET

This chart shows the closing price history over time for NKTR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Nektar Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/16/2022Howard W RobinCEOSell38,014$3.57$135,709.98979,793View SEC Filing Icon  
11/16/2022Jillian B. ThomsenCFOSell11,095$3.57$39,609.15323,764View SEC Filing Icon  
11/16/2022Jonathan ZalevskyInsiderSell13,460$3.57$48,052.20313,663View SEC Filing Icon  
9/23/2022Myriam CuretDirectorSell4,198$3.16$13,265.6831,777View SEC Filing Icon  
9/13/2022Karin EasthamDirectorSell21,267$3.61$76,773.8713,033View SEC Filing Icon  
8/18/2022Jonathan ZalevskyInsiderSell73,716$4.65$342,779.40327,123View SEC Filing Icon  
8/16/2022Howard W RobinCEOSell13,759$4.76$65,492.841,017,807View SEC Filing Icon  
8/16/2022Jillian B. ThomsenCAOSell2,006$4.76$9,548.56334,859View SEC Filing Icon  
8/16/2022Jonathan ZalevskyInsiderSell10,560$4.76$50,265.60400,839View SEC Filing Icon  
8/16/2022Mark Andrew WilsonSVPSell3,189$4.76$15,179.64281,188View SEC Filing Icon  
5/16/2022Gil M. LabrucherieCFOSell17,448$3.95$68,919.60312,905View SEC Filing Icon  
5/16/2022Howard W RobinCEOSell36,529$3.95$144,289.55620,941View SEC Filing Icon  
5/16/2022Jillian B. ThomsenCAOSell5,841$3.95$23,071.95170,427View SEC Filing Icon  
5/16/2022Jonathan ZalevskyInsiderSell21,673$3.95$85,608.35276,399View SEC Filing Icon  
5/16/2022Mark Andrew WilsonSVPSell3,136$3.95$12,387.20117,939View SEC Filing Icon  
2/16/2022Gil M. LabrucherieCFOSell7,579$10.95$82,990.05View SEC Filing Icon  
2/16/2022Howard W RobinCEOSell12,480$10.95$136,656.00View SEC Filing Icon  
2/16/2022Jillian B. ThomsenCAOSell2,363$10.95$25,874.85View SEC Filing Icon  
2/16/2022John NorthcottSVPSell4,852$10.95$53,129.40View SEC Filing Icon  
2/16/2022Jonathan ZalevskyInsiderSell10,912$10.95$119,486.40View SEC Filing Icon  
11/18/2021Gil M. LabrucherieCFOSell3,000$12.69$38,070.00View SEC Filing Icon  
11/16/2021Gil M. LabrucherieCFOSell21,149$13.16$278,320.84View SEC Filing Icon  
9/22/2021Myriam CuretDirectorSell3,665$17.78$65,163.70View SEC Filing Icon  
9/8/2021Robert ChessDirectorSell8,000$16.00$128,000.00282,273View SEC Filing Icon  
8/16/2021Gil M. LabrucherieCFOSell7,867$13.83$108,800.61View SEC Filing Icon  
8/16/2021Howard W. RobinCEOSell11,515$13.83$159,252.45424,123View SEC Filing Icon  
8/16/2021Jillian B. ThomsenCAOSell13,339$13.83$184,478.37View SEC Filing Icon  
8/16/2021Jonathan ZalevskyInsiderSell7,662$13.83$105,965.46View SEC Filing Icon  
8/16/2021Mark Andrew WilsonSVPSell1,910$13.83$26,415.30200,915View SEC Filing Icon  
7/21/2021Robert ChessDirectorSell3,524$16.81$59,238.44View SEC Filing Icon  
5/17/2021Gil M. LabrucherieCFOSell7,898$18.30$144,533.40View SEC Filing Icon  
5/17/2021Howard W RobinCEOSell11,560$18.30$211,548.00435,638View SEC Filing Icon  
5/17/2021Jillian B. ThomsenCAOSell13,391$18.30$245,055.30View SEC Filing Icon  
5/17/2021Jonathan ZalevskyInsiderSell31,111$18.30$569,331.30235,065View SEC Filing Icon  
5/17/2021Mark Andrew WilsonSVPSell1,917$18.30$35,081.10207,107View SEC Filing Icon  
5/12/2021Robert ChessDirectorSell8,000$19.34$154,720.00288,573View SEC Filing Icon  
4/14/2021Robert ChessDirectorSell8,000$18.98$151,840.00288,573View SEC Filing Icon  
2/4/2021Gil M. LabrucherieCFOSell50,000$19.81$990,500.00View SEC Filing Icon  
2/3/2021Howard W RobinCEOSell150,000$19.72$2,958,000.00608,693View SEC Filing Icon  
2/3/2021Mark Andrew WilsonSVPSell5,344$19.45$103,940.80View SEC Filing Icon  
2/2/2021Gil M. LabrucherieCFOSell50,000$20.17$1,008,500.00View SEC Filing Icon  
1/28/2021Jillian B. ThomsenCAOSell75,000$18.62$1,396,500.00View SEC Filing Icon  
12/15/2020Curet MyriamDirectorSell1,560$17.82$27,799.2019,240View SEC Filing Icon  
11/23/2020Jonathan ZalevskyInsiderSell16,380$16.40$268,632.00250,317View SEC Filing Icon  
9/28/2020Jeffrey Robert AjerDirectorSell3,250$17.25$56,062.5025,975View SEC Filing Icon  
9/25/2020Robert ChessDirectorSell5,500$17.75$97,625.00280,573View SEC Filing Icon  
9/21/2020Jeffrey Robert AjerDirectorSell2,250$19.74$44,415.0020,125View SEC Filing Icon  
9/17/2020Gil M. LabrucherieCFOSell2,000$19.96$39,920.00View SEC Filing Icon  
9/8/2020Robert ChessDirectorSell8,000$18.53$148,240.00284,973View SEC Filing Icon  
8/17/2020Gil M. LabrucherieCFOSell6,245$19.67$122,839.15View SEC Filing Icon  
8/17/2020Howard W RobinCEOSell11,885$19.67$233,777.95364,018View SEC Filing Icon  
8/17/2020Jillian B. ThomsenCAOSell1,367$19.67$26,888.89View SEC Filing Icon  
8/17/2020Jonathan ZalevskyInsiderSell26,200$19.67$515,354.00296,315View SEC Filing Icon  
8/17/2020Mark Andrew WilsonSVPSell1,529$19.67$30,075.43View SEC Filing Icon  
7/9/2020R Scott GreerDirectorSell15,009$25.00$375,225.00284,973View SEC Filing Icon  
4/15/2020Robert ChessDirectorSell8,000$18.38$147,040.00284,973View SEC Filing Icon  
3/11/2020Robert ChessDirectorSell8,000$16.79$134,320.00284,973View SEC Filing Icon  
2/18/2020Gil M. LabrucherieCFOSell5,938$22.35$132,714.30View SEC Filing Icon  
2/18/2020Howard W RobinCEOSell8,448$22.35$188,812.80384,871View SEC Filing Icon  
2/18/2020Jillian B. ThomsenCAOSell1,394$22.35$31,155.90View SEC Filing Icon  
2/18/2020Jonathan ZalevskyInsiderSell4,774$22.35$106,698.90327,073View SEC Filing Icon  
2/12/2020Robert ChessDirectorSell8,000$23.50$188,000.00284,973View SEC Filing Icon  
2/6/2020Jillian B. ThomsenCAOSell37,500$22.78$854,250.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Nektar Therapeutics (NASDAQ:NKTR)

96.99% of Nektar Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NKTR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Nektar Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/8/2022Bank of New York Mellon Corp1,719,478$5.50M0.0%+1.8%0.915%Search for SEC Filing on Google Icon
11/22/2022Teachers Retirement System of The State of Kentucky61,886$0.20M0.0%N/A0.033%Search for SEC Filing on Google Icon
11/21/2022California State Teachers Retirement System232,749$0.75M0.0%-1.8%0.124%Search for SEC Filing on Google Icon
11/16/2022Captrust Financial Advisors23,049$74K0.0%+600.4%0.012%Search for SEC Filing on Google Icon
11/16/2022Balyasny Asset Management LLC14,512$46K0.0%N/A0.008%Search for SEC Filing on Google Icon
11/16/2022Verus Capital Partners LLC41,008$0.13M0.0%N/A0.022%Search for SEC Filing on Google Icon
11/16/2022BNP Paribas Arbitrage SNC100,938$0.32M0.0%-67.9%0.054%Search for SEC Filing on Google Icon
11/15/2022Alliancebernstein L.P.1,239,854$3.97M0.0%-46.8%0.660%Search for SEC Filing on Google Icon
11/15/2022State Street Corp7,856,892$25.14M0.0%-10.0%4.180%Search for SEC Filing on Google Icon
11/15/2022Jacobs Levy Equity Management Inc.1,037,929$3.32M0.0%+355.3%0.552%Search for SEC Filing on Google Icon
11/15/2022Algert Global LLC476,412$1.53M0.1%+10.0%0.253%Search for SEC Filing on Google Icon
11/15/2022Thrivent Financial for Lutherans193,723$0.62M0.0%+5.9%0.103%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Advisers LP633,642$2.03M0.0%+285.1%0.337%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Investments LP841,775$2.69M0.0%+98.8%0.448%Search for SEC Filing on Google Icon
11/15/2022UBS Asset Management Americas Inc.167,179$0.54M0.0%-14.2%0.089%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.23,164,944$74.13M0.0%+12.4%12.325%Search for SEC Filing on Google Icon
11/15/2022Price T Rowe Associates Inc. MD261,627$0.84M0.0%-6.3%0.139%Search for SEC Filing on Google Icon
11/15/2022Primecap Management Co. CA16,422,443$52.55M0.1%-0.8%8.737%Search for SEC Filing on Google Icon
11/15/2022Marshall Wace LLP31,144$100K0.0%N/A0.017%Search for SEC Filing on Google Icon
11/15/2022Edgestream Partners L.P.1,047,636$3.35M0.3%-1.8%0.557%Search for SEC Filing on Google Icon
11/15/2022Federated Hermes Inc.837,065$2.68M0.0%+675.2%0.445%Search for SEC Filing on Google Icon
11/15/2022Bank of New York Mellon Corp1,719,478$5.50M0.0%+1.8%0.915%Search for SEC Filing on Google Icon
11/15/2022Bayesian Capital Management LP30,300$97K0.0%-63.1%0.016%Search for SEC Filing on Google Icon
11/15/2022Bellevue Group AG14,800$47K0.0%-48.6%0.008%Search for SEC Filing on Google Icon
11/15/2022BlackRock Inc.35,050,519$112.16M0.0%+11.0%18.649%Search for SEC Filing on Google Icon
11/15/2022Caxton Associates LP50,531$0.16M0.0%-55.6%0.027%Search for SEC Filing on Google Icon
11/14/2022Macquarie Group Ltd.258,941$0.84M0.0%-1.5%0.138%Search for SEC Filing on Google Icon
11/14/2022Royal Bank of Canada15,614$50K0.0%+86.4%0.008%Search for SEC Filing on Google Icon
11/14/2022Tudor Investment Corp Et Al267,063$0.86M0.0%-44.8%0.142%Search for SEC Filing on Google Icon
11/14/2022Cubist Systematic Strategies LLC204,913$0.66M0.0%-21.9%0.109%Search for SEC Filing on Google Icon
11/14/2022PDT Partners LLC307,953$0.99M0.1%-63.0%0.164%Search for SEC Filing on Google Icon
11/14/2022Ergoteles LLC19,191$61K0.0%N/A0.010%Search for SEC Filing on Google Icon
11/14/2022Nuveen Asset Management LLC647,431$2.07M0.0%-1.9%0.344%Search for SEC Filing on Google Icon
11/14/2022Metropolitan Life Insurance Co NY7,890$25K0.0%-28.5%0.004%Search for SEC Filing on Google Icon
11/14/2022Hsbc Holdings PLC80,667$0.26M0.0%+88.2%0.043%Search for SEC Filing on Google Icon
11/14/2022Pictet Asset Management SA860,218$2.75M0.0%+149.9%0.458%Search for SEC Filing on Google Icon
11/14/2022Cipher Capital LP14,512$46K0.0%N/A0.008%Search for SEC Filing on Google Icon
11/14/2022Hennion & Walsh Asset Management Inc.223,047$0.71M0.0%-4.6%0.119%Search for SEC Filing on Google Icon
11/10/2022Credit Suisse AG172,816$0.55M0.0%-2.7%0.092%Search for SEC Filing on Google Icon
11/10/2022Connor Clark & Lunn Investment Management Ltd.10,709$34K0.0%-71.7%0.006%Search for SEC Filing on Google Icon
11/10/2022ExodusPoint Capital Management LP31,049$99K0.0%N/A0.017%Search for SEC Filing on Google Icon
11/10/2022Dimensional Fund Advisors LP1,252,372$4.01M0.0%-25.8%0.666%Search for SEC Filing on Google Icon
11/10/2022Tower Research Capital LLC TRC 14,568$47K0.0%+81.9%0.008%Search for SEC Filing on Google Icon
11/9/2022Amalgamated Bank83,139$0.27M0.0%+3.6%0.044%Search for SEC Filing on Google Icon
11/8/2022Mutual of America Capital Management LLC37,283$0.12M0.0%+19.2%0.020%Search for SEC Filing on Google Icon
11/8/2022New York State Common Retirement Fund115,300$0.37M0.0%+13.0%0.062%Search for SEC Filing on Google Icon
11/7/2022Inspire Investing LLC64,771$0.21M0.0%+15.9%0.035%Search for SEC Filing on Google Icon
11/7/2022Arete Wealth Advisors LLC11,000$35K0.0%N/A0.006%Search for SEC Filing on Google Icon
11/7/2022Quantbot Technologies LP47,596$0.15M0.0%+1,537.9%0.025%Search for SEC Filing on Google Icon
11/7/2022Jump Financial LLC139,400$0.45M0.0%-19.7%0.074%Search for SEC Filing on Google Icon
11/7/2022Profund Advisors LLC14,313$46K0.0%-61.3%0.008%Search for SEC Filing on Google Icon
11/4/2022CM Management LLC50,000$0.16M0.2%-60.0%0.027%Search for SEC Filing on Google Icon
11/4/2022Yousif Capital Management LLC150,630$0.48M0.0%-2.0%0.080%Search for SEC Filing on Google Icon
11/4/2022Russell Investments Group Ltd.83,081$0.26M0.0%+2,290.1%0.044%Search for SEC Filing on Google Icon
11/4/2022Grandfield & Dodd LLC25,061$80K0.0%-25.9%0.013%Search for SEC Filing on Google Icon
11/4/2022Ieq Capital LLC68,388$0.22M0.0%-6.2%0.036%Search for SEC Filing on Google Icon
11/3/2022Barclays PLC144,454$0.46M0.0%-43.5%0.077%Search for SEC Filing on Google Icon
11/2/2022Landscape Capital Management L.L.C.24,423$78K0.0%-10.9%0.013%Search for SEC Filing on Google Icon
11/2/2022Victory Capital Management Inc.40,595$0.13M0.0%+15.4%0.022%Search for SEC Filing on Google Icon
11/1/2022Great West Life Assurance Co. Can239,973$0.77M0.0%+27.7%0.128%Search for SEC Filing on Google Icon
10/31/2022SG Americas Securities LLC21,172$68K0.0%-80.5%0.011%Search for SEC Filing on Google Icon
10/28/2022State of New Jersey Common Pension Fund D515,907$1.65M0.0%-11.9%0.275%Search for SEC Filing on Google Icon
10/28/2022Comerica Bank141,551$0.51M0.0%-10.8%0.076%Search for SEC Filing on Google Icon
10/28/2022Klingman & Associates LLC35,582$0.11M0.0%N/A0.019%Search for SEC Filing on Google Icon
10/26/2022Allspring Global Investments Holdings LLC132,586$0.42M0.0%-6.5%0.071%Search for SEC Filing on Google Icon
10/25/2022Raymond James & Associates10,001$32K0.0%-35.8%0.005%Search for SEC Filing on Google Icon
10/24/2022Xponance Inc.10,171$33K0.0%N/A0.005%Search for SEC Filing on Google Icon
10/20/2022State of Alaska Department of Revenue129,745$0.42M0.0%-7.9%0.069%Search for SEC Filing on Google Icon
10/19/2022Louisiana State Employees Retirement System89,500$0.29M0.0%N/A0.048%Search for SEC Filing on Google Icon
9/16/2022Federated Hermes Inc.107,978$0.41M0.0%N/A0.058%Search for SEC Filing on Google Icon
8/19/2022Walleye Capital LLC486,724$1.85M0.0%+29.9%0.260%Search for SEC Filing on Google Icon
8/18/2022Goldman Sachs Group Inc.701,883$2.67M0.0%+42.8%0.375%Search for SEC Filing on Google Icon
8/16/2022Thrivent Financial for Lutherans183,006$0.70M0.0%+21.8%0.098%Search for SEC Filing on Google Icon
8/16/2022Price T Rowe Associates Inc. MD279,255$1.06M0.0%+168.6%0.149%Search for SEC Filing on Google Icon
8/16/2022Prudential Financial Inc.192,550$0.73M0.0%+3.6%0.103%Search for SEC Filing on Google Icon
8/16/2022Capula Management Ltd21,648$82K0.0%N/A0.012%Search for SEC Filing on Google Icon
8/16/2022Corton Capital Inc.15,304$58K0.1%N/A0.008%Search for SEC Filing on Google Icon
8/16/2022Delphia USA Inc.16,991$65K0.0%N/A0.009%Search for SEC Filing on Google Icon
8/15/2022Occudo Quantitative Strategies LP290,489$1.10M0.1%+186.9%0.155%Search for SEC Filing on Google Icon
8/15/2022AQR Capital Management LLC499,592$1.90M0.0%+174.3%0.267%Search for SEC Filing on Google Icon
8/15/2022State Street Corp8,728,968$33.17M0.0%+50.5%4.658%Search for SEC Filing on Google Icon
8/15/2022PDT Partners LLC832,507$3.16M0.3%+27.5%0.444%Search for SEC Filing on Google Icon
8/15/2022Cubist Systematic Strategies LLC262,259$1M0.0%-70.6%0.140%Search for SEC Filing on Google Icon
8/15/2022UBS Asset Management Americas Inc.194,902$0.74M0.0%-35.9%0.104%Search for SEC Filing on Google Icon
8/13/2022Teacher Retirement System of Texas28,703$0.11M0.0%-25.6%0.015%Search for SEC Filing on Google Icon
8/13/2022Vantage Consulting Group Inc10,673$41K0.0%N/A0.006%Search for SEC Filing on Google Icon
8/13/2022American International Group Inc.98,673$0.38M0.0%+517.6%0.053%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp892,352$3.39M0.0%-8.3%0.476%Search for SEC Filing on Google Icon
8/12/2022Virtus ETF Advisers LLC70,964$0.27M0.1%+141.9%0.038%Search for SEC Filing on Google Icon
8/12/2022LPL Financial LLC20,818$79K0.0%-34.9%0.011%Search for SEC Filing on Google Icon
8/12/2022Credit Suisse AG177,598$0.67M0.0%-14.0%0.095%Search for SEC Filing on Google Icon
8/12/2022Rafferty Asset Management LLC71,396$0.27M0.0%+205.5%0.038%Search for SEC Filing on Google Icon
8/12/2022FMR LLC191,338$0.73M0.0%-23.4%0.102%Search for SEC Filing on Google Icon
8/12/2022BNP Paribas Arbitrage SA314,396$1.20M0.0%+30.5%0.168%Search for SEC Filing on Google Icon
8/12/2022Edgestream Partners L.P.1,066,788$4.05M0.3%+71.0%0.569%Search for SEC Filing on Google Icon
8/12/2022Financial Advocates Investment Management12,434$47K0.0%-57.4%0.007%Search for SEC Filing on Google Icon
8/12/2022Rhumbline Advisers553,249$2.10M0.0%+25.2%0.295%Search for SEC Filing on Google Icon
8/11/2022Primecap Management Co. CA16,551,322$62.90M0.1%-3.0%8.832%Search for SEC Filing on Google Icon
8/11/2022Healthcare of Ontario Pension Plan Trust Fund599,118$2.28M0.0%N/A0.320%Search for SEC Filing on Google Icon
8/11/2022UBS Group AG12,437$47K0.0%-33.2%0.007%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Nektar Therapeutics logo
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, squamous cell carcinoma of the head and neck, and adjuvant melanoma; phase 2 clinical trial for the treatment of renal cell carcinoma, non-small cell lung cancer, and urothelial cancer; phase 1/2A clinical trial to treat squamous cell carcinoma of the head and neck; phase 1/2 clinical trial for the treatment of solid tumors; and phase 1B clinical trial to treat COVID-19. It is also developing NKTR-358, a cytokine Treg stimulant that is in phase 2 clinical trial for the treatment of systemic lupus erythematosus and ulcerative colitis, as well as phase 1B clinical trial to treat atopic dermatitis and psoriasis; NKTR-255, an IL-15 receptor agonist, which is in phase 1/2 clinical trial for the treatment of non-Hodgkin's lymphoma and multiple myeloma, and head and neck cancer and colorectal cancer; and NKTR-262, a toll-like receptor agonist that is in phase 1/2 clinical trial to treat solid tumors, as well as various other drug candidates. The company has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma S.A.; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; Amgen Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Baxalta Incorporated; Eli Lilly and Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. Nektar Therapeutics was incorporated in 1990 and is headquartered in San Francisco, California.
Read More on Nektar Therapeutics

Today's Range

Now: $2.90
Low: $2.82
High: $2.99

50 Day Range

MA: $3.46
Low: $2.80
High: $4.28

52 Week Range

Now: $2.90
Low: $2.73
High: $15.94

Volume

913,819 shs

Average Volume

2,219,893 shs

Market Capitalization

$545.06 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1

Who are the company insiders with the largest holdings of Nektar Therapeutics?

Nektar Therapeutics' top insider investors include:
  1. Howard W Robin (CEO)
  2. Howard W Robin (CEO)
  3. Jonathan Zalevsky (Insider)
  4. Jillian B Thomsen (CAO)
  5. Jillian B Thomsen (CFO)
  6. Gil M Labrucherie (CFO)
  7. Robert Chess (Director)
  8. Mark Andrew Wilson (SVP)
  9. Myriam Curet (Director)
  10. Curet Myriam (Director)
  11. Karin Eastham (Director)
  12. Gil M Labrucherie (CFO)
  13. Jillian B Thomsen (CAO)
  14. John Northcott (SVP)
Learn More about top insider investors at Nektar Therapeutics.

Who are the major institutional investors of Nektar Therapeutics?

Nektar Therapeutics' top institutional shareholders include:
  1. BlackRock Inc. — 18.65%
  2. Vanguard Group Inc. — 12.32%
  3. Primecap Management Co. CA — 8.74%
  4. State Street Corp — 4.18%
  5. Bank of New York Mellon Corp — 0.91%
  6. Bank of New York Mellon Corp — 0.91%
Learn More about top institutional investors of Nektar Therapeutics stock.

Which major investors are selling Nektar Therapeutics stock?

Within the previous quarter, NKTR stock was sold by these institutional investors:
  1. Alliancebernstein L.P.
  2. State Street Corp
  3. PDT Partners LLC
  4. Dimensional Fund Advisors LP
  5. Tudor Investment Corp Et Al
  6. BNP Paribas Arbitrage SNC
  7. Primecap Management Co. CA
  8. Barclays PLC
In the previous year, company insiders that have sold Nektar Therapeutics company stock include:
  1. Howard W Robin (CEO)
  2. Howard W Robin (CEO)
  3. Jonathan Zalevsky (Insider)
  4. Jillian B Thomsen (CAO)
  5. Jillian B Thomsen (CFO)
  6. Gil M Labrucherie (CFO)
  7. Robert Chess (Director)
  8. Mark Andrew Wilson (SVP)
  9. Myriam Curet (Director)
Learn More investors selling Nektar Therapeutics stock.

Which major investors are buying Nektar Therapeutics stock?

In the last quarter, NKTR stock was purchased by institutional investors including:
  1. BlackRock Inc.
  2. Vanguard Group Inc.
  3. Jacobs Levy Equity Management Inc.
  4. Federated Hermes Inc.
  5. Pictet Asset Management SA
  6. Two Sigma Advisers LP
  7. Two Sigma Investments LP
  8. Louisiana State Employees Retirement System